Literature DB >> 21191030

Roles of VP4 and NSP1 in determining the distinctive replication capacities of simian rotavirus RRV and bovine rotavirus UK in the mouse biliary tract.

Ningguo Feng1, Adrish Sen, Marie Wolf, Phuoc Vo, Yasutaka Hoshino, Harry B Greenberg.   

Abstract

Rotavirus replication and virulence are strongly influenced by virus strain and host species. The rotavirus proteins VP3, VP4, VP7, NSP1, and NSP4 have all been implicated in strain and species restriction of replication; however, the mechanisms have not been fully determined. Simian (RRV) and bovine (UK) rotaviruses have distinctive replication capacities in mouse extraintestinal organs such as the biliary tract. Using reassortants between UK and RRV, we previously demonstrated that the differential replication of these viruses in mouse embryonic fibroblasts is determined by the respective NSP1 proteins, which differ substantially in their abilities to degrade interferon (IFN) regulatory factor 3 (IRF3) and suppress the type I IFN response. In this study, we used an in vivo model of rotavirus infection of mouse gallbladder with UK × RRV reassortants to study the genetic and mechanistic basis of systemic rotavirus replication. We found that the low-replication phenotype of UK in biliary tissues was conferred by UK VP4 and that the high-replication phenotype of RRV was conferred by RRV VP4 and NSP1. Viruses with RRV VP4 entered cultured mouse cholangiocytes more efficiently than did those with UK VP4. Reassortants with RRV VP4 and UK NSP1 genes induced high levels of expression of IRF3-dependent p54 in biliary tissues, and their replication was increased 3-fold in IFN-α/β and -γ receptor or STAT1 knockout (KO) mice compared to wild-type mice. Our data indicate that systemic rotavirus strain-specific replication in the murine biliary tract is determined by both viral entry mediated by VP4 and viral antagonism of the host innate immune response mediated by NSP1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21191030      PMCID: PMC3067955          DOI: 10.1128/JVI.02408-10

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  26 in total

1.  Nondefective rotavirus mutants with an NSP1 gene which has a deletion of 500 nucleotides, including a cysteine-rich zinc finger motif-encoding region (nucleotides 156 to 248), or which has a nonsense codon at nucleotides 153-155.

Authors:  K Taniguchi; K Kojima; S Urasawa
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

2.  Reassortant rotaviruses as potential live rotavirus vaccine candidates.

Authors:  K Midthun; H B Greenberg; Y Hoshino; A Z Kapikian; R G Wyatt; R M Chanock
Journal:  J Virol       Date:  1985-03       Impact factor: 5.103

3.  Molecular basis of rotavirus virulence: role of gene segment 4.

Authors:  P A Offit; G Blavat; H B Greenberg; H F Clark
Journal:  J Virol       Date:  1986-01       Impact factor: 5.103

4.  Roles of outer capsid proteins as determinants of pathogenicity and host range restriction of avian rotaviruses in a suckling mouse model.

Authors:  Yoshio Mori; Mohammed Ali Borgan; Mutsuyo Takayama; Naoto Ito; Makoto Sugiyama; Nobuyuki Minamoto
Journal:  Virology       Date:  2003-11-10       Impact factor: 3.616

5.  Reactogenicity and immunogenicity of a high-titer rhesus rotavirus-based quadrivalent rotavirus vaccine.

Authors:  J Flores; I Perez-Schael; M Blanco; A M Rojas; E Alfonzo; I Crespo; W Cunto; A L Pittman; A Z Kapikian
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

6.  IRF3 inhibition by rotavirus NSP1 is host cell and virus strain dependent but independent of NSP1 proteasomal degradation.

Authors:  Adrish Sen; Ningguo Feng; Khalil Ettayebi; Michele E Hardy; Harry B Greenberg
Journal:  J Virol       Date:  2009-08-05       Impact factor: 5.103

7.  Group A rotaviruses produce extrahepatic biliary obstruction in orally inoculated newborn mice.

Authors:  M Riepenhoff-Talty; K Schaekel; H F Clark; W Mueller; I Uhnoo; T Rossi; J Fisher; P L Ogra
Journal:  Pediatr Res       Date:  1993-04       Impact factor: 3.756

8.  Murine rotavirus genes encoding outer capsid proteins VP4 and VP7 are not major determinants of host range restriction and virulence.

Authors:  R L Broome; P T Vo; R L Ward; H F Clark; H B Greenberg
Journal:  J Virol       Date:  1993-05       Impact factor: 5.103

9.  Serotypic similarity and diversity of rotaviruses of mammalian and avian origin as studied by plaque-reduction neutralization.

Authors:  Y Hoshino; R G Wyatt; H B Greenberg; J Flores; A Z Kapikian
Journal:  J Infect Dis       Date:  1984-05       Impact factor: 5.226

10.  Identification of group A rotavirus genes associated with virulence of a porcine rotavirus and host range restriction of a human rotavirus in the gnotobiotic piglet model.

Authors:  Y Hoshino; L J Saif; S Y Kang; M M Sereno; W K Chen; A Z Kapikian
Journal:  Virology       Date:  1995-05-10       Impact factor: 3.616

View more
  25 in total

Review 1.  Clues to the etiology of bile duct injury in biliary atresia.

Authors:  Cara L Mack; Amy G Feldman; Ronald J Sokol
Journal:  Semin Liver Dis       Date:  2013-02-08       Impact factor: 6.115

2.  Reverse Genetics System for a Human Group A Rotavirus.

Authors:  Takahiro Kawagishi; Jeffery A Nurdin; Misa Onishi; Ryotaro Nouda; Yuta Kanai; Takeshi Tajima; Hiroshi Ushijima; Takeshi Kobayashi
Journal:  J Virol       Date:  2020-01-06       Impact factor: 5.103

3.  Reverse Genetics Reveals a Role of Rotavirus VP3 Phosphodiesterase Activity in Inhibiting RNase L Signaling and Contributing to Intestinal Viral Replication In Vivo.

Authors:  Yanhua Song; Ningguo Feng; Liliana Sanchez-Tacuba; Linda L Yasukawa; Lili Ren; Robert H Silverman; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-04-16       Impact factor: 5.103

4.  Full genome characterization of human G3P[6] and G3P[9] rotavirus strains in Lebanon.

Authors:  Nischay Mishra; Lina Reslan; Mohsen El-Husseini; Hawraa Raoof; Marc Finianos; Cheng Guo; Riddhi Thakkar; Adlette Inati; Ghassan Dbaibo; W Ian Lipkin; Hassan Zaraket
Journal:  Infect Genet Evol       Date:  2019-12-05       Impact factor: 3.342

5.  The rhesus rotavirus gene encoding VP4 is a major determinant in the pathogenesis of biliary atresia in newborn mice.

Authors:  Wei Wang; Bryan Donnelly; Alexander Bondoc; Sujit K Mohanty; Monica McNeal; Richard Ward; Karol Sestak; Shan Zheng; Greg Tiao
Journal:  J Virol       Date:  2011-06-22       Impact factor: 5.103

6.  The early interferon response to rotavirus is regulated by PKR and depends on MAVS/IPS-1, RIG-I, MDA-5, and IRF3.

Authors:  Adrish Sen; Andrea J Pruijssers; Terence S Dermody; Adolfo García-Sastre; Harry B Greenberg
Journal:  J Virol       Date:  2011-02-09       Impact factor: 5.103

7.  A Point Mutation in the Rhesus Rotavirus VP4 Protein Generated through a Rotavirus Reverse Genetics System Attenuates Biliary Atresia in the Murine Model.

Authors:  Sujit K Mohanty; Bryan Donnelly; Phylicia Dupree; Inna Lobeck; Sarah Mowery; Jaroslaw Meller; Monica McNeal; Greg Tiao
Journal:  J Virol       Date:  2017-07-12       Impact factor: 5.103

8.  Serial Passaging of the Human Rotavirus CDC-9 Strain in Cell Culture Leads to Attenuation: Characterization from In Vitro and In Vivo Studies.

Authors:  Theresa Kathrina Resch; Yuhuan Wang; Sungsil Moon; Baoming Jiang
Journal:  J Virol       Date:  2020-07-16       Impact factor: 5.103

9.  An Optimized Reverse Genetics System Suitable for Efficient Recovery of Simian, Human, and Murine-Like Rotaviruses.

Authors:  Liliana Sánchez-Tacuba; Ningguo Feng; Nathan J Meade; Kenneth H Mellits; Philippe H Jaïs; Linda L Yasukawa; Theresa K Resch; Baoming Jiang; Susana López; Siyuan Ding; Harry B Greenberg
Journal:  J Virol       Date:  2020-08-31       Impact factor: 5.103

10.  Permissive replication of homologous murine rotavirus in the mouse intestine is primarily regulated by VP4 and NSP1.

Authors:  Ningguo Feng; Linda L Yasukawa; Adrish Sen; Harry B Greenberg
Journal:  J Virol       Date:  2013-05-22       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.